![Icagen, Inc. Logo](/news-release/logo/217869/0/217869.jpg?lastModified=12%2F09%2F2016%2023%3A18%3A31&size=2)
Icagen Completes Enrollment in Phase II Allergen Challenge Asthma Trial
23 avr. 2009 08h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., April 23, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today reported the completion of enrollment in the Company's Phase II proof-of-concept study of senicapoc in...
![Icagen, Inc. Logo](/news-release/logo/217869/0/217869.jpg?lastModified=12%2F09%2F2016%2023%3A18%3A31&size=2)
Icagen Presents Results of Phase I Program of ICA-105665
17 avr. 2009 08h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., April 17, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today presented results of the Company's Phase I program for ICA-105665, the Company's lead drug candidate...
![Icagen, Inc. Logo](/news-release/logo/217869/0/217869.jpg?lastModified=12%2F09%2F2016%2023%3A18%3A31&size=2)
Icagen to Present Results of Phase I Program of ICA-105665
13 avr. 2009 16h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., April 13, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that results of the Company's Phase I program for ICA-105665, the Company's lead drug...
![Icagen, Inc. Logo](/news-release/logo/217869/0/217869.jpg?lastModified=12%2F09%2F2016%2023%3A18%3A31&size=2)
Icagen Provides Update On ICA-105665
31 mars 2009 07h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., March 31, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that it has received notification from the FDA that, based on a review of certain...
![Icagen, Inc. Logo](/news-release/logo/217869/0/217869.jpg?lastModified=12%2F09%2F2016%2023%3A18%3A31&size=2)
Icagen Initiates Study of Senicapoc in Exercise Induced Asthma
11 mars 2009 08h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., March 11, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced the initiation of a Phase II proof-of-concept study of senicapoc, a novel orally available...
![Icagen, Inc. Logo](/news-release/logo/217869/0/217869.jpg?lastModified=12%2F09%2F2016%2023%3A18%3A31&size=2)
Icagen Reports Fourth Quarter and Full Year 2008 Financial Results
11 mars 2009 08h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., March 11, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the fourth quarter and full year ended...
![Icagen, Inc. Logo](/news-release/logo/217869/0/217869.jpg?lastModified=12%2F09%2F2016%2023%3A18%3A31&size=2)
Icagen to Announce Fourth Quarter and Full Year 2008 Results and Conduct Conference Call On March 11, 2009
27 févr. 2009 07h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Feb. 27, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced it will release financial results for the fourth quarter and full year 2008 on Wednesday,...
![Icagen, Inc. Logo](/news-release/logo/217869/0/217869.jpg?lastModified=12%2F09%2F2016%2023%3A18%3A31&size=2)
Icagen to Present At the 11th Annual BIO CEO & Investor Conference On February 10, 2009
02 févr. 2009 07h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Feb. 2, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that executive management will participate in the 11th Annual BIO CEO and Investor Conference...
![Icagen, Inc. Logo](/news-release/logo/217869/0/217869.jpg?lastModified=12%2F09%2F2016%2023%3A18%3A31&size=2)
Icagen to Present At the JP Morgan Healthcare Conference On January 15, 2009
06 janv. 2009 08h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Jan. 6, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that executive management will participate in the 27th Annual JP Morgan Healthcare Conference...
Icagen Adopts Shareholder Rights Plan
03 déc. 2008 07h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Dec. 3, 2008 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that its Board of Directors has adopted a shareholder rights plan designed to ensure that all...